HSPA5 and plasma cell myeloma: Multiple myeloma cells’ resistance to bortezomib, a proteasome inhibitor, is associated with the S-glutathionylation of the binding immunoglobulin protein (BiP), with Cys41-SSG being important for ATPase and Cys420-SSG for foldase [291].